Year : 2019 | Volume
: 30 | Issue : 1 | Page : 1-
Better care of urological diseases
Stephen Shei-Dei Yang
Department of Urology, Taipei Tzu Chi Hospital, New Taipei; School of Medicine, Buddhist Tzu Chi University, Hualien, Taiwan
Stephen Shei-Dei Yang
Department of Urology, Taipei Tzu Chi Hospital, New Taipei; School of Medicine, Buddhist Tzu Chi University, Hualien
|How to cite this article:|
Yang SS. Better care of urological diseases.Urol Sci 2019;30:1-1
|How to cite this URL:|
Yang SS. Better care of urological diseases. Urol Sci [serial online] 2019 [cited 2021 May 12 ];30:1-1
Available from: https://www.e-urol-sci.com/text.asp?2019/30/1/1/249262
Happy New Chinese Pig Year! Pig means home and rich for all Chinese! Wish readers around the world have a happy and prosperous year!
This issue is to mark the 30 years of publication of Urological Science. Thanks to all editors, reviewers, and authors; our Blue Journal is now recognized widely in Asia and the world. Through double-blinded peer review system and open access without publication fee to authors, we have established a good platform for urological scientists to publish their quality researches in this journal. The reviewers' comments are another way of teaching urological science and medical practice to the authors. The authors' innovations are inspirations of better care of urological diseases now and the future. Urological Science welcomes authors to submit their original works and also invites reviewers to join the volunteer team to guard the quality of the journal and medicine.
In this issue, Guo JC reviews the hot Nobel's issue of immunotherapy in urological oncology. “Programmed Death-1 (PD-1) and Programmed Death Ligand-1 (PD-L1) Blockade for Advanced Urothelial Carcinoma” is an article for all modern urologists. Asia and the world alike are getting old, and multiple comorbidities are common in our urological patients. Chou YC highlights the correlation of strokes and lower urinary tract symptoms/dysfunction. The neurosurgical view would be interesting to functional urologists.
Urolithiasis is prevalent in Taiwan and Stone-Belt countries. Managing big renal stone, particularly the complete staghorn stone, is always a clinical challenge. Chang SK introduced a simple way of good hemostasis in the tubeless percutaneous nephrolithotomy (PCNL). Mane D summarized the results of miniperc XS in the treatment of renal stones. Refinement of surgical technique and instrument has made PCNL a key player in the treatment of renal stones.
Pheochromocytoma can be difficult to diagnose and treat. Yu CC reported the 20 years' experience from a tertiary center in Taiwan. Robotic assisted radical prostatectomy (RaRP) has gained wide acceptance in Taiwan. More men want to have better sexual function after RaRP. Ou YC reported what were the effects of Cialis in preserving sexual function in these men. The National Health Insurance Data Bank provides a good cohort to observe the real-world outcomes or correlation of many diseases in Taiwan. Chang SJ used this data bank to report the incidence of secondary repair after primary repair in pediatric inguinal hernia. All the reviews and original articles are clinically relevant and will help you get a better care of patients!